SCHEMBL21020507

SCHEMBL21020507

Cc1cc(-c2cc(F)c(=O)n(Cc3ccc4nnn(C)c4c3)c2)nc(S(=O)(=O)CCCC(=O)N(c2ccccc2)C2CCC2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SDHB P21912 7/20 0.38
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA4 P22748 2/20 0.32
▸ CA5A P35218 2/20 0.32
▸ CA7 P43166 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ CA13 Q8N1Q1 2/20 0.32
▸ CA14 Q9ULX7 2/20 0.32
▸ OPRM1 P35372 1/20 0.31
▸ PSEN1 P49768 1/20 0.31
▸ PSEN2 P49810 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ APH1B Q8WW43 1/20 0.31
▸ NCSTN Q92542 1/20 0.31
▸ APH1A Q96BI3 1/20 0.31
▸ PSENEN Q9NZ42 1/20 0.31
▸ S1PR4 O95977 1/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21020128 0.98 SDHB (0.38) SDHBCA12CA1CA2CA4
SCHEMBL21020508 0.89 SDHB (0.32) SDHB
SCHEMBL21019916 0.89 SDHB (0.39) SDHBS1PR4LMNATP53HPGD
SCHEMBL21019843 0.87 SDHB (0.33) SDHB
SCHEMBL21019476 0.86 SDHB (0.39) SDHBTP53SMN1; SMN2
SCHEMBL21020127 0.84 SDHB (0.40) SDHBLMNATP53SMN1; SMN2
SCHEMBL21020509 0.83 SDHB (0.33) SDHB
SCHEMBL23897350 0.80 SDHB (0.52) SDHBLMNAKMT2ASMN1; SMN2
SCHEMBL21020496 0.80 CHRM1 (0.35) SDHB
SCHEMBL20985685 0.79 LMNA (0.35) SDHBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 — — US disclosed
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 — — US disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152960-A1 Apoptosis Inhibitors BAX, SDHA, SDHB SDHB 3/4885CA12 3096/4885CA1 1080/4885
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885CA12 3096/4885CA1 1080/4885
US-11034680-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885CA12 3096/4885CA1 1080/4885
US-20210309647-A1 Apoptosis Inhibitors BAX, SDHA, SDHB SDHB 3/4885CA12 3096/4885CA1 1080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback